Member Info for Laura2022

Just need Admiral Ackbar now

I would hope new or more recent new members also may consider buying

This could be linked with the potential JV mentioned in the June 2024 DoseMeRx update

Very nice to see

Strange you've not commented on SCE which you were ramping 2 weeks ago and is now virtually bust

Why did you have a 9 year gap in posting on LSE

Why have you ramped SCE and FAB but then decided to target PYC

Yes..was a buy

Toffee

I agree and let's not forget virtually no other AIM CEOs are buying on open market and certainly not one with lowest renumeration on AIM (£70k versus £250/300 average )

The important bit for me is I'm not aware of any other AIM CEO who has bought on the open market and certainly not one whose renumeration is lowest on AIM and yet has delivered record contract revenues

23 mins : PS discusses the slide headed 'Immediate Growth Levers - Growth and Profit' and mentions that 'many of you will have seen this slide before as I have used it in a number of other presentations'. Firstly good to see the word 'Profit' mentioned, but secondly , I do not recall seeing this slide before, but I may well be mistaken. It could have been used to attract potential investors for the last funding round (it could also conceivably have been in presentations to potential future buyers/partners/long term investors)

26 mins & 32 mins : Much on the development and projected commercialisation of the personalised dosing tool through its partnership with DosemeRx. PS mentions mentions that he is 'conscious that we need to extract value from this tool'. He also notes we 'also intend to explore other avenues for this tool'. Looks like this is all progressing very well and could be transformative for PYC

27 mins/30 mins : Head of Modelling will be 'an expert in the field of modelling and simulation with broad networks across the industry'. Scheduled to start in November

29 mins : With reference to Biostatistics PS mentions ' We are exploring strategic options to enable accelerated growth' . 'This is something we are very much actively exploring at the moment'

31 mins : Scientific publications. 'Progressing a number of scientific papers at the moment' . 'Two have been submitted back to the respective journals and one is about to be submitted' PS mentions 'being able to credentialise your technical skills through peer reviews in scientific journals is a very important and very useful marketing tool for us'.

'Hopefully we can announce their publication very soon'

33 mins : PREDICT-ONC Trial at Blackpool Hospital 'going through final stages of ethical and regulatory approval'. 'We hope to announce the official start of the trial very soon' I though this would have been a little further advanced, but will presumably result in more of the Innovate grant income being reflected in the current financial year'. The end date of the trial remains unchanged

PS is highly organised and motivated and is building a very strong team to drive sustainable growth. I like what I see

Many things due as per the recent presentation msuk

1st open market buy ...well done PS ...

AIM CEOs who earn x 4 more haven't done this across 100s other stocks

And despite these very low AIM wages the start of open market director buying

Hopefully more to follow

Peter Sargent, Chief Executive Officer and Director of the Company, has acquired, via market purchases, 459,090 new ordinary shares of 0.4p in the Company ("Ordinary Shares") at a price of 0.66p per Ordinary Share.

There are 700mln shares and only 63mln traded ( about 10%) so it's hard to tell as yet any II patterns

And PYC is the gem

1) very low salaries...eg £70k CEO v £300K Ceo like WSG

2) low overheads

3)growing revenues

4) growing pipeline

5) cashed up

6] growth markets of drug discovery and biostatistics

7]potential for large uplifts..eg if VAL201 comes in or personalised dosing app takes off in America

7) very low shares in issue (only 230mln)

But .despite all this you still "apparently " hold

Mmmm

WSJ: Trump Team Proposes 20-Year Freeze on Ukraine’s NATO Bid in Exchange for Peace

The alleged peace plan also suggests freezing the current front lines by establishing a demilitarized zone without using US or UN forces to police it.

Are you able to put a link please KingH

Perhaps linked to the CLNS from Oct

Some chunky trades today

balance of 2,777,778 New Shares will be issued and admitted to trading on AIM later following receipt by the Company of the remaining £25,000 of the £150,000 draw down from the loan facility with Sanderson. A further announcement will be made in due course.

Tricky

PYC has often done 200%+ and even that would only be £4.8mln market cap

I think we'll get plenty of news either side of the AGM